Page last updated: 2024-10-22

albuterol and Pulmonary Alveolar Proteinosis

albuterol has been researched along with Pulmonary Alveolar Proteinosis in 1 studies

Albuterol: A short-acting beta-2 adrenergic agonist that is primarily used as a bronchodilator agent to treat ASTHMA. Albuterol is prepared as a racemic mixture of R(-) and S(+) stereoisomers. The stereospecific preparation of R(-) isomer of albuterol is referred to as levalbuterol.
albuterol : A member of the class of phenylethanolamines that is 4-(2-amino-1-hydroxyethyl)-2-(hydroxymethyl)phenol having a tert-butyl group attached to the nirogen atom. It acts as a beta-adrenergic agonist used in the treatment of asthma and chronic obstructive pulmonary disease (COPD).

Pulmonary Alveolar Proteinosis: A PULMONARY ALVEOLI-filling disease, characterized by dense phospholipoproteinaceous deposits in the alveoli, cough, and DYSPNEA. This disease is often related to, congenital or acquired, impaired processing of PULMONARY SURFACTANTS by alveolar macrophages, a process dependent on GRANULOCYTE-MACROPHAGE COLONY-STIMULATING FACTOR.

Research Excerpts

ExcerptRelevanceReference
"Key Words: Pulmonary alveolar proteinosis, Child, Atopy, Wheezing."1.72First Documented Case of Pulmonary Alveolar Proteinosis with Atopy Presenting Secondary to CSFR2B Mutation. ( Avci, A; Kiyan, G; Ozcan, D; Sasihuseyinoglu, AS, 2022)

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's0 (0.00)24.3611
2020's1 (100.00)2.80

Authors

AuthorsStudies
Sasihuseyinoglu, AS1
Ozcan, D1
Avci, A1
Kiyan, G1

Other Studies

1 other study available for albuterol and Pulmonary Alveolar Proteinosis

ArticleYear
First Documented Case of Pulmonary Alveolar Proteinosis with Atopy Presenting Secondary to CSFR2B Mutation.
    Journal of the College of Physicians and Surgeons--Pakistan : JCPSP, 2022, Volume: 32, Issue:8

    Topics: Albuterol; Bronchoalveolar Lavage; Child; Granulocyte-Macrophage Colony-Stimulating Factor; Humans;

2022